Erlotinib Hydrochloride Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4095966
- 143 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Erlotinib Hydrochloride market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Erlotinib Hydrochloride market segmented into
Non-small Cell Lung Cancer
100mg
150mg
Based on the end-use, the global Erlotinib Hydrochloride market classified into
Non-small Cell Lung Cancer
Pancreatic Cancer
Based on geography, the global Erlotinib Hydrochloride market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Roche
Cipla
Mylan
Teva
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Beacon Pharmaceuticals
Raichem Lifesciences
United Biotech
CJ Corporation
Vivimed Labs
Boryung Pharmaceutical
Taj Pharmaceuticals
Pharmascience
Natco Pharma
Intas Pharmaceuticals
RPG Life Sciences
Pharmascience
Schwarz Pharma
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals
Chugai Pharmaceutical
DKSH
Firma Chun Cheong
Kremers Urban Pharmaceuticals
Ortat
Zuellig Pharma
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ERLOTINIB HYDROCHLORIDE INDUSTRY
2.1 Summary about Erlotinib Hydrochloride Industry
2.2 Erlotinib Hydrochloride Market Trends
2.2.1 Erlotinib Hydrochloride Production & Consumption Trends
2.2.2 Erlotinib Hydrochloride Demand Structure Trends
2.3 Erlotinib Hydrochloride Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 25mg
4.2.2 100mg
4.2.3 150mg
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Non-small Cell Lung Cancer
4.3.2 Pancreatic Cancer
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 25mg
5.2.2 100mg
5.2.3 150mg
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Non-small Cell Lung Cancer
5.3.2 Pancreatic Cancer
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 25mg
6.2.2 100mg
6.2.3 150mg
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Non-small Cell Lung Cancer
6.3.2 Pancreatic Cancer
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 25mg
7.2.2 100mg
7.2.3 150mg
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Non-small Cell Lung Cancer
7.3.2 Pancreatic Cancer
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 25mg
8.2.2 100mg
8.2.3 150mg
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Non-small Cell Lung Cancer
8.3.2 Pancreatic Cancer
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 25mg
9.2.2 100mg
9.2.3 150mg
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Non-small Cell Lung Cancer
9.3.2 Pancreatic Cancer
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Roche
10.1.2 Cipla
10.1.3 Mylan
10.1.4 Teva
10.1.5 OSI Pharmaceuticals
10.1.6 Glenmark Pharmaceuticals
10.1.7 Beacon Pharmaceuticals
10.1.8 Raichem Lifesciences
10.1.9 United Biotech
10.1.10 CJ Corporation
10.1.11 Vivimed Labs
10.1.12 Boryung Pharmaceutical
10.1.13 Taj Pharmaceuticals
10.1.14 Pharmascience
10.1.15 Natco Pharma
10.1.16 Intas Pharmaceuticals
10.1.17 RPG Life Sciences
10.1.18 Pharmascience
10.1.19 Schwarz Pharma
10.1.20 Dr. Reddy’s Laboratories
10.1.21 Glenmark Pharmaceuticals
10.1.22 Chugai Pharmaceutical
10.1.23 DKSH
10.1.24 Firma Chun Cheong
10.1.25 Kremers Urban Pharmaceuticals
10.1.26 Ortat
10.1.27 Zuellig Pharma
10.2 Erlotinib Hydrochloride Sales Date of Major Players (2017-2020e)
10.2.1 Roche
10.2.2 Cipla
10.2.3 Mylan
10.2.4 Teva
10.2.5 OSI Pharmaceuticals
10.2.6 Glenmark Pharmaceuticals
10.2.7 Beacon Pharmaceuticals
10.2.8 Raichem Lifesciences
10.2.9 United Biotech
10.2.10 CJ Corporation
10.2.11 Vivimed Labs
10.2.12 Boryung Pharmaceutical
10.2.13 Taj Pharmaceuticals
10.2.14 Pharmascience
10.2.15 Natco Pharma
10.2.16 Intas Pharmaceuticals
10.2.17 RPG Life Sciences
10.2.18 Pharmascience
10.2.19 Schwarz Pharma
10.2.20 Dr. Reddy’s Laboratories
10.2.21 Glenmark Pharmaceuticals
10.2.22 Chugai Pharmaceutical
10.2.23 DKSH
10.2.24 Firma Chun Cheong
10.2.25 Kremers Urban Pharmaceuticals
10.2.26 Ortat
10.2.27 Zuellig Pharma
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Erlotinib Hydrochloride Product Type Overview
2.Table Erlotinib Hydrochloride Product Type Market Share List
3.Table Erlotinib Hydrochloride Product Type of Major Players
4.Table Brief Introduction of Roche
5.Table Brief Introduction of Cipla
6.Table Brief Introduction of Mylan
7.Table Brief Introduction of Teva
8.Table Brief Introduction of OSI Pharmaceuticals
9.Table Brief Introduction of Glenmark Pharmaceuticals
10.Table Brief Introduction of Beacon Pharmaceuticals
11.Table Brief Introduction of Raichem Lifesciences
12.Table Brief Introduction of United Biotech
13.Table Brief Introduction of CJ Corporation
14.Table Brief Introduction of Vivimed Labs
15.Table Brief Introduction of Boryung Pharmaceutical
16.Table Brief Introduction of Taj Pharmaceuticals
17.Table Brief Introduction of Pharmascience
18.Table Brief Introduction of Natco Pharma
19.Table Brief Introduction of Intas Pharmaceuticals
20.Table Brief Introduction of RPG Life Sciences
21.Table Brief Introduction of Pharmascience
22.Table Brief Introduction of Schwarz Pharma
23.Table Brief Introduction of Dr. Reddy’s Laboratories
24.Table Brief Introduction of Glenmark Pharmaceuticals
25.Table Brief Introduction of Chugai Pharmaceutical
26.Table Brief Introduction of DKSH
27.Table Brief Introduction of Firma Chun Cheong
28.Table Brief Introduction of Kremers Urban Pharmaceuticals
29.Table Brief Introduction of Ortat
30.Table Brief Introduction of Zuellig Pharma
31.Table Products & Services of Roche
32.Table Products & Services of Cipla
33.Table Products & Services of Mylan
34.Table Products & Services of Teva
35.Table Products & Services of OSI Pharmaceuticals
36.Table Products & Services of Glenmark Pharmaceuticals
37.Table Products & Services of Beacon Pharmaceuticals
38.Table Products & Services of Raichem Lifesciences
39.Table Products & Services of United Biotech
40.Table Products & Services of CJ Corporation
41.Table Products & Services of Vivimed Labs
42.Table Products & Services of Boryung Pharmaceutical
43.Table Products & Services of Taj Pharmaceuticals
44.Table Products & Services of Pharmascience
45.Table Products & Services of Natco Pharma
46.Table Products & Services of Intas Pharmaceuticals
47.Table Products & Services of RPG Life Sciences
48.Table Products & Services of Pharmascience
49.Table Products & Services of Schwarz Pharma
50.Table Products & Services of Dr. Reddy’s Laboratories
51.Table Products & Services of Glenmark Pharmaceuticals
52.Table Products & Services of Chugai Pharmaceutical
53.Table Products & Services of DKSH
54.Table Products & Services of Firma Chun Cheong
55.Table Products & Services of Kremers Urban Pharmaceuticals
56.Table Products & Services of Ortat
57.Table Products & Services of Zuellig Pharma
58.Table Market Distribution of Major Players
59.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
60.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
61.Table Global Erlotinib Hydrochloride Market Forecast (Million USD) by Region 2021f-2026f
62.Table Global Erlotinib Hydrochloride Market Forecast (Million USD) Share by Region 2021f-2026f
63.Table Global Erlotinib Hydrochloride Market Forecast (Million USD) by Demand 2021f-2026f
64.Table Global Erlotinib Hydrochloride Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
